Loading clinical trials...
Loading clinical trials...
: A Phase III Multicenter, Randomized, Parallel Group, Controlled, Double Blind Study to Investigate the Safety and Efficacy of Inhaled Mannitol Over 12 Months in the Treatment of Bronchiectasis.
Conditions
Interventions
Inhaled mannitol
Matched control
Locations
83
United States
National Jewish Medical and Research Center
Denver, Colorado, United States
University of Connecticut Health Center, Pulmonary Division
Farmington, Connecticut, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, United States
University of Miami
Miami, Florida, United States
Florida Pulmonary Research
Winter Park, Florida, United States
The University of Chicago Hospitals
Chicago, Illinois, United States
Start Date
November 1, 2009
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
April 29, 2016
NCT06166056
NCT02779478
NCT07274631
NCT07289464
NCT06670937
NCT07192705
Lead Sponsor
Syntara
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions